Global Infant Phototherapy Device Industry to 2030

company logo

company logo

Dublin, June 20, 2022 (GLOBE NEWSWIRE) — The “Infant Phototherapy Device Market by Light Source (Fluorescent Lamps, Light Emitting Diodes, Quartz Halogen Lamps, and Gas Discharge Tubes), Configuration and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offer.

The global infant phototherapy device market was valued at $91,930.5 thousand in 2020 and is expected to reach $132,077.53 thousand by 2030, growing at a CAGR of 3.7% from 2021 to 2030.

Phototherapy is one of the most effective and convenient methods of treating infants suffering from neonatal jaundice. It is often used to lower levels of bilirubin (the substance that causes jaundice) in infants. According to estimates from the National Collaborating Center for Women’s and Children’s Health (UK), nearly 60% of full-term babies and 80% of premature babies develop jaundice in the first week after birth. Jaundice in newborns can also be caused by other non-physiological causes, such as blood type incompatibility, hemolysis, sepsis, bruising, and liver enzyme deficiency. During phototherapy, a baby is held in a plastic crib and exposed to a type of light that is absorbed through the skin. During this process, the bilirubin in the baby’s body is converted to a much simpler, water-soluble form, which is easily excreted through feces and urine.

The major factors driving the growth of the global infant phototherapy device market include the increase in the prevalence of neonatal jaundice and advantages of phototherapy over other treatment methods. Moreover, technological developments in the field of phototherapy for children are driving the market growth. However, side effects of phototherapy treatment limit market growth.

The infant phototherapy device market is segmented on the basis of light lamp type, configuration, end user, and region. Depending on the type of light lamp, the market is divided into fluorescent lamps, light-emitting diodes (LEDs), quartz halogen lamps and gas discharge tubes. Depending on the configuration, the market is divided into mobile device and fixed device. By end user, the market is split into hospitals and neonatal clinics. In terms of region, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.

This report provides comprehensive competitive analysis and profiles of prominent market players operating in Atom Medical Corporation, AVI Healthcare Pvt. Ltd. Equalize Health Inc., General Electric Company, Ibis Medical Equipment & Systems Pvt. Ltd., Natus Medical Incorporated, Ningbo David Medical Device Co., LTD., Novos Medical Devices San. Tic. Imp. & Ihr. Ltd. Sti., Weyer GmbH, Zhengzhou Dison Instrument and Meter Co., Ltd.

Main benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimates to clarify the impending investment pockets.

  • It provides quantitative analysis from 2020 to 2030, which is expected to enable stakeholders to capitalize on the prevailing market opportunities

  • Analysis by light source helps understand the different types of light sources used in baby phototherapy devices

  • A comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities

  • The key players are profiled and their strategies are thoroughly analyzed in order to understand the competitive prospects of the global market

Main topics covered:

Chapter 1 Introduction

Chapter 2: Summary

Chapter 3: Market Landscape
3.1. Market definition and scope
3.2. Key findings
3.2.1. Best Investment Bags
3.2.2. Best Winning Strategies
3.3. Porter’s Five Forces Analysis
3.3.1. Supplier bargaining power
3.3.2. Threat of new entrants
3.3.3. Threat of substitutes
3.3.4. Competitive Battle
3.3.5. Bargaining power among buyers
3.4. Market share analysis/positioning of top players
3.4.1. Market share analysis/positioning of top players 2020
3.5. Market dynamics
3.5.1. drivers
3.5.2. limits
3.5.3. Possibilities
3.6. Covid-19 Impact Analysis

Chapter 4: Infant Phototherapy Device Market, by Product
4.1. Market overview
4.1.1 Market size and forecast, by product
4.2. Fluorescent lamps
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Regions
4.2.3. Market share analysis, by country
4.3. Light Emitting Diodes
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Regions
4.3.3. Market share analysis, by country
4.4. Quartz Halogen Bulbs
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Regions
4.4.3. Market share analysis, by country
4.5. gas discharge pipes
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, by Regions
4.5.3. Market share analysis, by country

Chapter 5: Infant Phototherapy Device Market, by Configuration
5.1. Market overview
5.1.1 Market size and forecast, by configuration
5.2. Mobile device
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Regions
5.2.3. Market share analysis, by country
5.3. Fixed device
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Regions
5.3.3. Market share analysis, by country

Chapter 6: Infant Phototherapy Device Market, by End User
6.1. Market overview
6.1.1 Market size and forecast, by end user
6.2. Hospital
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.2.3. Market share analysis, by country
6.3. Neonatal Clinics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, by Regions
6.3.3. Market share analysis, by country

Chapter 7: Infant Phototherapy Device Market by Regions

Chapter 8: Company Profiles
8.1. Atom Medical Corporation
8.1.1. Corporate overview
8.1.2. key figures
8.1.3. Business Snapshot
8.1.4. Operating Business Segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Avi Healthcare Pvt. Ltd
8.2.1. Corporate overview
8.2.2. key figures
8.2.3. Business Snapshot
8.2.4. Operating Business Segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Equalize Heath, Inc
8.3.1. Corporate overview
8.3.2. key figures
8.3.3. Business Snapshot
8.3.4. Operating Business Segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. GE Healthcare
8.4.1. Corporate overview
8.4.2. key figures
8.4.3. Business Snapshot
8.4.4. Operating Business Segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Natus Medical Incorporated
8.5.1. Corporate overview
8.5.2. key figures
8.5.3. Business Snapshot
8.5.4. Operating Business Segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Ningbo David Medical Device Co. Ltd
8.6.1. Corporate overview
8.6.2. key figures
8.6.3. Business Snapshot
8.6.4. Operating Business Segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Ibis Medical Equipment and Systems Pvt. Ltd
8.7.1. Corporate overview
8.7.2. key figures
8.7.3. Business Snapshot
8.7.4. Operating Business Segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti
8.8.1. Corporate overview
8.8.2. key figures
8.8.3. Business Snapshot
8.8.4. Operating Business Segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Weyer GmbH
8.9.1. Corporate overview
8.9.2. key figures
8.9.3. Business Snapshot
8.9.4. Operating Business Segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Zhengzhou Dison Instrument and Meter Co. Ltd
8.10.1. Corporate overview
8.10.2. key figures
8.10.3. Business Snapshot
8.10.4. Operating Business Segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments

For more information about this report, visit https://www.researchandmarkets.com/r/2cjrsh

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Comment

Your email address will not be published.